Glioblastoma Clinical Trials in Beijing, Beijing Municipality
10 recruitingBeijing, Beijing Municipality, China
Showing 1–10 of 10 trials
Recruiting
Phase 1Phase 2
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Breast CancerLiver CancerNon-small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech85 enrolled1 locationNCT07410494
Recruiting
Phase 1Phase 2
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Colorectal, CancerEsophageal CancerOvarian Cancer+12 more
Essen Biotech83 enrolled1 locationNCT07410676
Recruiting
Phase 1Phase 2
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd.42 enrolled11 locationsNCT07093814
Recruiting
Not Applicable
Allogeneic γδT Cells in Glioblastoma
Glioblastoma Multiforme (GBM)Glioblastoma (GBM)
Peking University Third Hospital18 enrolled3 locationsNCT07144735
Recruiting
Phase 1
BC008-1A Injection for Recurrent CNS WHO G4 Glioma
GliomaGlioblastoma WHO Grade IVGlioma Tumor Recurrence+2 more
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.40 enrolled1 locationNCT06773481
Recruiting
Phase 1
Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
NeoplasmsSmall Cell Lung Carcinoma (SCLC)Glioblastoma, Adult
Chipscreen Biosciences, Ltd.102 enrolled2 locationsNCT06902350
Recruiting
Phase 2
A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
Recurrent Glioblastoma
Sichuan Baili Pharmaceutical Co., Ltd.20 enrolled1 locationNCT06598787
Recruiting
Phase 1Phase 2
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Brain MetastasesBrain TumorBrain Cancer+4 more
Essen Biotech85 enrolled1 locationNCT06640582
Recruiting
Phase 1
Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
Glioblastoma MultiformeGlioma, Malignant
Beijing Neurosurgical Institute30 enrolled1 locationNCT06585527
Recruiting
Phase 1
Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
Recurrent Glioblastoma
Beijing Tiantan Hospital10 enrolled1 locationNCT05577091